Oligonucleotide conjugates carrying carbohydrates at the 5'-end have been prepared. Glucose, fucose and saccharides containing glucose at the non-reducing end were attached to DNA strands using the classical phosphoramidite chemistry. Two types of spacers and a dendron scaffold helped to obtain a diversity of sugar presentations in the DNA conjugates. Cellular surface adsorption and cellular uptake of carbohydrate oligonucleotide antisense sequences were measured using flow cytometric analysis.
INTRODUCTION
In the last two decades new compounds based on the use of small synthetic nucleic acids have shown promising results as potential drugs (1, 2) . Oligonucleotides have been used for the inhibition of a specific gene by blocking gene translation or gene transcription or by stimulating the degradation of a particular messenger RNA. Several strategies have been developed for this purpose. In the antisense strategy, synthetic oligonucleotides complementary to the messenger RNA of a given gene have been used to inhibit translation of messenger RNA to protein (3, 4) . In the antigene strategy, triplex-forming oligonucleotides may interact with double-stranded DNA inhibiting DNA transcription (5-7). More recently, in the siRNA strategy, small RNA duplexes complementary to messenger RNA sequences bind a protein complex named RISC. The complex formed by the antisense or guide RNA strand and RISC is able to catalyze the efficient degradation of a specific messenger RNA, lowering the amount of target protein (8) (9) (10) .
Among the problems found during the development of oligonucleotides as drugs are their degradation by exonucleases under physiological conditions, and particularly their low cell uptake due to their highly polar character and large size. Most of the improvements in the design of nucleic acid derivatives have been directed to enhance stability against nucleases and/or to improve cellular uptake without hindering the hybridisation properties that are vital for the efficient gene inhibitory properties of the oligonucleotides. Conjugation of siRNA to different delivery carriers such as lipids (11) , polymers (12, 13) or peptides (14) has been reported for improved delivery of siRNA. Moreover, cationic carriers are among the most efficient strategies for cell uptake although many of them exhibit severe cytotoxicity (15) . At the same time, covalent conjugation of oligonucleotides to peptides or to hydrophobic moieties has been used to facilitate internalization (16, 17) . For example, cholesterol-DNA and siRNA conjugates have shown improved inhibitory properties (18) (19) (20) .
A possible alternative to enhance oligonucleotide uptake is the preparation of carbohydrate oligonucleotide conjugates (COCs) that may use sugar binding membrane receptors to mediate cell entry. Different COCs have been synthesized up to date (16, 21, 22) but only a few have been experimentally tested. Recently, antisense oligonucleotides conjugated to multivalent hyaluronan disaccharide did not show higher or more specific uptake than unconjugated oligonucleotides in a cell line expressing the hyaluronan receptor CD44 (23) . In contrast, Mahato et al. has utilized mannose 6-phosphate-bovine serum albumin and galactose polyethyleneglycol conjugated to oligonucleotides for site-specific delivery into hepatic cells when injected to rats (24, 25) . Also, siRNA carrying lactose linked through a polyethylene glycol branch at the 5'-end of the sense strand immersed in a polyionic complex micelle has been shown to enhance gene silencing in hepatoma cells (26) .
Glucose is essential for cell survival and its transport is facilitated by members of the GLUT protein family. We reasoned that oligonucleotide conjugates carrying glucose moieties could bind to GLUT receptors and facilitate internalization via receptor-mediated endocytosis. In the present work we have prepared oligonucleotides modified at the 5'-end with glucose or glucose-containing saccharides at the non-reducing end (Figure 1 ). Two types of spacers and a dendron scaffold have been used to probe a diversity of sugar presentations. A carbohydrate-oligonucleotide conjugate containing a fucose unit was also prepared as a negative control. We have covalently bound the carbohydrate moieties to a singlestranded oligodeoxynucleotide antisense sequence and finally added a fluorescence tag. The corresponding labeled carbohydrate-oligonucleotide conjugates have been used to study their cellsurface binding and their cellular uptake in HeLa and U87.CD4.CXCR4 cell lines using flow cytometric analysis.
EXPERIMENTAL PROCEDURES
General methods and materials. All chemicals were obtained from chemical suppliers and used without further purification, unless otherwise noted. All reactions were monitored by TLC on precoated Silica-Gel 60 plates F254, and detected by heating with Mostain (500 ml of 10% H 2 SO 4 , 25g of (NH 4 The product was purified by silica gel column chromathography using as eluent Hex-EtOAc Solvents were then removed and the crude was purified by silica gel column chromatography by using Maltotriose-C2-5'-CTCTCGCACCCATCTCTCTCCTTCT-3'-NH 2 . After ammonia deprotection (overnight, 55 ºC) the resulting oligodeoxynucleotides were purified by HPLC (see conditions below).
2-Hydroxyethyl-O-(2,3,4, 6-tetra-
The purified products were analyzed by MALDI-TOF mass spectrometry. Conditions: 10 min. linear gradient from 0-30% B). In both cases, solvent A: 5% acetonitrile in 100 mM triethylammonium acetate (pH=7) and solvent B: 70% acetonitrile in 100 mM triethylammonium acetate (pH=7).
Mass spectrometry. MALDI-TOF spectra were performed using a Perseptive Voyager DETMRP mass spectrometer, equipped with nitrogen laser at 337 nm using a 3ns pulse. The matrix used contained 2,4,6-trihydroxyacetophenone (THAP, 10 mg/ml in ACN/ water 1:1) and ammonium citrate (50 mg/ ml in water). penicillin/streptomycin (100 units/ml and 100 µg/ml, respectively) (Invitrogen) in a humidified atmosphere consisting of 5% CO 2 and 95% air. Human astroglioma U87.CD4.CXCR4 cells were also supplemented with 1 µg/ml puromicine (Sigma) and 300 µg/ml geneticin (G-418 sulphate) (Invitrogen).
Cell-surface adsorption studies by flow cytometric analysis. Cells were seeded into 24-well plates 48
hours prior to treatment in DMEM supplemented with 10% FBS, in the absence or presence of glucose 
Synthesis of carbohydrate oligonucleotide conjugates (2-7). Oligodeoxynucleotides carrying
carbohydrates at the 5'-end were prepared using the appropriate carbohydrate phosphoramidites (Schemes 1 and 2) and the commercial dendrimer symmetric doubler phosphoramidite. We selected the well-known antisense oligonucleotide sequence GEM91 (5'-CTCTCGCACCCATCTCTCTCCTTCT) that was targeted to the translational initiation site of the Gag mRNA of HIV (32) . We designed oligonucleotide sequences that carried an amino group at the 3'-end so that a carboxyl-activated fluorescent label could be attached at a subsequent step. We selected the commercially available 3'-amino-modifier C7 CPG for the amino modification of the COC's. The oligonucleotide glycoconjugates temperature. In all cases a major peak was obtained ( Figure 3 ) and the desired fluorescently labeled oligonucleotides were isolated in good yields (67-93%). Finally, a control labelled DNA oligonucleotide (8) was prepared using the same conditions described above.
Cell-surface adsorption and uptake by flow cytometric analysis. We measured cell-surface adsorption of the carbohydrate oligonucleotide conjugates (9-14, Fig. 1 ) and the control labeled DNA oligonucleotide (8, Fig. 1 ) both in the presence and absence of glucose in the medium. HeLa cells and U87.CD4.CXCR4 cells were seeded on 24-well culture plates, in the presence (5.5 mM) or absence of glucose for 48 h until preconfluency at 37 ºC. Then, the medium was replaced and cells were incubated with 5 µM bioconjugate for 1 h at 4 ºC in the presence or absence of glucose. Note that incubation at 4 ºC allows oligonucleotide adsorption onto the cell-surface but not endocytosis-dependent cellular internalization (35) . After incubation cells were washed and resuspended in ice-cold PBS and analyzed by flow cytometry (Figure 4 ). In the absence of glucose, an overall increase in fluorescence intensity is observed for all the oligonucleotides analyzed in comparison to the data observed when glucose was present in the medium. This behavior was similar for both HeLa and U87.CD4.CXCR4 cells and it could be due to the starving conditions suffered by the cells during long periods of time (i.e., 48 h). In general, although there are only small differences among all the oligonucleotides analyzed, a slight increment in fluorescence could be observed for oligonucleotides 11 and 13, for both cell types in the presence or absence of glucose.
To determine the influence of glucose units in the oligonucleotide and the relevance of the different spatial presentation in the cellular uptake, the carbohydrate oligonucleotide conjugates labeled with Alexa 488 (9-14, Fig. 1 ) and the control labeled DNA oligonucleotide (8, Fig. 1 ) were incubated with HeLa cells and U87.CD4.CXCR4 cells. The incubation was performed under standard conditions with 2 µM oligonucleotide for 2 h at 37 ºC, both in the absence and in the presence of glucose (5.5 mM). After washing the fluorescence intensity was determined by flow cytometry ( Figure 5 ). Flow cytometry revealed that the fluorescence intensity of the cells was higher for DNA glycoconjugates 11 and 13 than for glycoconjugates 9, 10, 12, 14 and the control labeled DNA oligonucleotide without sugar modification 8. This behavior was observed both in HeLa and U87.CD4.CXCR4 cells (Fig. 5, A and B) , in the absence or presence of glucose, these differences being much smaller when glucose was present in the medium. It seems that oligonucleotides with the glucose moiety linked through longer spacers (15 and 18 atom distance in COC's 11 and 13, respectively) showed better incorporation into the target cell than those with glucose linked through shorter spacers (4 atom distance in COC 9). Moreover, high multivalency of glucose, as in glycoconjugate 14, seems to hinder cell uptake maybe due to its high structural volume.
CONCLUSIONS
We have efficiently synthesized carbohydrate oligonucleotide conjugates with sugar moieties bound at correspond to the analytical HPLC profiles of purified conjugates using X-Bridge TMOST C18
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